Cargando…
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G
Controlled human infection models (CHIMs) are useful for vaccine development. To improve on existing models, we developed a CHIM using a lyophilized preparation of Shigella sonnei strain 53G produced using current good manufacturing practice (cGMP). Healthy adults were enrolled in an open-label dose...
Autores principales: | Frenck, Robert W., Dickey, Michelle, Suvarnapunya, Akamol E., Chandrasekaran, Lakshmi, Kaminski, Robert W., Clarkson, Kristen A., McNeal, Monica, Lynen, Amanda, Parker, Susan, Hoeper, Amy, Mani, Sachin, Fix, Alan, Maier, Nicole, Venkatesan, Malabi M., Porter, Chad K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568646/ https://www.ncbi.nlm.nih.gov/pubmed/32968005 http://dx.doi.org/10.1128/mSphere.00416-20 |
Ejemplares similares
-
Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G
por: Clarkson, Kristen A., et al.
Publicado: (2020) -
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
por: Frenck, Robert W., et al.
Publicado: (2021) -
Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
por: Clarkson, Kristen A., et al.
Publicado: (2021) -
Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and shedding
por: Venkatesan, Malabi M., et al.
Publicado: (2021) -
Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
por: Talaat, Kawsar R, et al.
Publicado: (2019)